57th Annual Irish Neurological Association Meeting Programme
The 57th Annual Neurological Association Meeting, under the presidency of Dr. Donal Costigan, will take place online on Thursday 27 and Friday 28 May 2021.
Thursday May 27th
12.30 Log-in to virtual INA meeting via IICN website link
12.45 Opening and Welcome to Second virtual INA Meeting.
Dr. Donal Costigan, INA President 2021
13.00 Session I – Epilepsy.
Chairs: Prof. Amre Shahwan and Dr. Michael Kinney
14.30 Session II – Virtual Poster Session I
Delegates view posters at vINA Meeting page on IICN website
|Group 1 - Posters A – D|
Movement Disorders, Multiple Sclerosis, Inflammatory and Immunological, Medication audit - Inflammatory.
Group 2 - Posters E – H
Stroke & Vascular, Neoplasm, Headache, Consult Service and Education.
15.15 Session III – Neuromuscular and Ataxia.
Chairs: Dr. Seán Connolly and Dr. John McConville
16.35 Session IV – Poster to Platform
Chairs: Dr. Roisin Lonergan and Dr. Brian Sweeney
16.50 Session V – Irish Neurological Association Business Meeting
Chair: Dr. Donal Costigan
Friday May 28th
08.00 Session VI – Neuropsychology Seminar
Guest Lecturer: Dr. Alberto Blanco-Campal, with Dr. Paul Crowley and Dr. Donal Costigan
09.00 Session VII – Cognitive and Parkinson’s Disease
Chairs: Dr. Seán O’Riordan and Dr. Karen Doherty
10.20 Session VIII – Virtual Poster Session II
Delegates view posters at vINA Meeting page on IICN website
|Group 3 - Posters I – K|
Epilepsy, Medication audit Epilepsy, Sleep Coma Encephalopathy.
Group 4 - Posters L – N
Neuromuscular, Neurophysiology EMG, Ataxia
10.50 Session IX – Multiple Sclerosis and Neuroinflammation
Chairs: Dr. Lisa Costelloe and Dr. Orla Gray
12.10 Session X – Noel Callaghan Guest Lecture
“The spectrum of Tourette Disorder: From semiology, to treatment, and new genetic vistas”.
Guest Lecturer: Dr. Jorge Juncos
14.00 Neuro Kahoot
Chair: Dr. John McHugh
14.30 Session XI – Neurosurgery and Stroke
Chairs: Prof. Jack Phillips and Dr. Ferghal McVerry
15.49 Session XII – Poster to Platform
Chairs: Dr. Ronan Kilbride and Dr. Sinead Murphy
16.10 Presidental Address and Announcement of Prizes
Dr. Donal Costigan
16.40 Close of Meeting
vINA Meeting Scientific Programme
vINA Meeting 2021 - Session I Epilepsy
O1 13.00 Three-Year Outcomes in a Cohort of Patients with Newly Diagnosed Epilepsy.
Stack J, O’Reilly E, Costello D.
O2 13.13 Fatal presentation of an adult-onset urea cycle disorder.
Donlon E, McGettigan J, C Gaffney C, O’Connor D, Ahmad M, Chaila E.
O3 13.26 Diagnostic yield of exome sequencing in patients with ultra-refractory epilepsy without intellectual disability.
Doyle M, Benson K, Moloney P, Carton R, Kearney H, El Naggar H, Widdess-Walsh P, Cavalleri GL, Delanty N.
O4 13.39 An rud is annamh is iontach: a case of ictal speech – as Gaeilge.
Doyle M, Kearney H, Moloney P, Kilbride R, El Naggar H, Delanty N, Widdess-Walsh P.
O5 13.54 “Of course it was Loki… It’s always Loki.”
Barr S, Todd R, Boucher J, Campbell L, Scullin P, Donaghy C, Kinney MO, Hughes SE.
O6 14.07 Everolimus for drug-resistant seizures in tuberous sclerosis complex: an Irish experience.
Moloney P, Behan C, Doherty CP, Costello DJ, El-Naggar H, Delanty N.
O7 14.20 Imaging blood-brain barrier integrity in temporal lobe epilepsy by dynamic contrast-enhanced MRI.
Greene C, Hanley N, O'Rourke C, Connolly R, O'Keeffe E, Campbell M, Doherty CP.
Session II - Virtual Poster Session 1
14.35 Group 1
Posters A , B, C and D
A Movement Disorders
B - Multiple Sclerosis
C - Inflammatory and Immunological
D - Medication audit - Inflammatory
14.45 Group 2
Posters E, F, G and H
E - Stroke and Vascular
F - Neoplasm
G - Headache
H - Consult Service and Education
Session III - Neuromuscular and Ataxia
O8 15.15 Expanding the phenotype of a second Irish variant causing hereditary amyloidogenic transthyretin amyloidosis.
Asad M, McNamara B, Kearney P, Ryan A.
O9 15.28 Analysis of yield and utility of whole exome and whole genome sequencing from a specialized Adult Neurology clinic.
Gunko A, Murphy M, Bogdanova-Mihaylova P, Walsh R, Murphy S.
O10 15.41 'Epidemiology and survival trends for Motor Neurone Disease in Northern Ireland 2015-2019'.
McCluskey G, Duddy W, Haffey S, Morrison K, Donaghy C, Duguez S.
O11 15.56 Slowly Progressive Myopathy and a Slowly Progressive Diagnosis.
Fives C, Jansen M, Costello D, Oldfors A, Hedberg-Oldfors C, Bermingham N.
O12 16.09 A fascinating case: Acute onset inflammatory demyelinating neuropathy with nephrotic syndrome associated with pan-neurofascin antibodies.
Doherty N, McMonagle P, McConville J.
O13 16.22 'A portrait on CANVAS'.
Kelly M, Bogdanova-Mihaylova P, Alexander M, Reilly M, Houlden H, Cortese A, Walsh R, Murphy S.
Session IV - Poster to Platform
16.35 Two Posters from Session II selected for Platform Presentations by Chairpersons Dr. Roisin Lonergan
Dr. Brian Sweeney
Session V - Irish Neurological Association Business Meeting
16.50 Meeting of members of the Irish Neurological Association
Session VI - Neuropsychology Symposium
08.00 Neuropsychology Seminar - Ask the Expert [covid icon] The neuropsychologist, Dr Alberto Blanco-Campal, demonstrates the neuropsychological evaluation with a special focus on the process-based approach, emphasising the qualitative analysis of test performance, and noting problems in the Covid era, with questions and comments from Drs Paul Crowley and Donal Costigan.
Session VII - Cognitive and Parkinson;s Disease
O14 09.00 Radiological features of primary progressive aphasias: a longitudinal quantitative neuroimaging study'.
McKenna MC, Hutchinson S, Bede P.
O15 09.13 Plasma amyloid-beta ratios in autosomal dominant Alzheimer’s disease: the influence of genotype.
O'Connor A, Alston D, Panne J, Blennow K, Henrik Zetterberg, Fox NC
O16 09.26 An epidemiological, clinical and radiological study of cerebral amyloid angiopathy-related inflammation in Northern Ireland.
Todd R, McKenna E, McConville J, McDonnell GV, McCormick M, McVerry F, Gray O, Fulton A, Craig J, Gordon P, Herron B/ Healy E, McCarron M.
O17 09.41 Causes and consequences of falls in an autopsy population.
Vrbanic L, Donnelly A, Heffernan J, Coony M, Walsh A, Heany C, Howley R, Farrell M, Brett F.
O18 09.54 A 6 month audit of DAT scan requesting in University Hospital Galway.
Gordon B, Joyce E, Davy S, Nevin R, Counihan T.
O19 10.07 Genetic determinants of Parkinson's disease.
Session VIII - Virtual Poster Session 2
10.20 Group 3 Posters I - K
I - Epilepsy
J - Medication audit, Epilepsy
K - Sleep Coma Encephalopathy
10.30 Group 4 Posters L - N
L - Neuromuscular
M - Neurophysiology EMG
N - Ataxia
Session IX Multiple Sclerosis and Neuroinflammation
O20 10.50 A Disease Modifying Therapy (DMT) Panel for Multiple Sclerosis: Experience of the first 2 years.
McKee J, Sproule L, Gormley N, Kee R, Kennedy F, Ramsay S, Flynn P, Nelson A, Cartmill G, Turley N, Droogan A, Gray O, Campbell J, Hughes S, McDonnell GV.
O21 11.03 An audit of investigation and management of viral encephalitis in Tallaght University Hospital (TUH).
Hanahoe A, Prior AR, Walsh R, Murphy S, McCabe D, McCarthy A, O’Dowd S.
O22 11.16 COVID-19 in people with Multiple Sclerosis: tertiary referral hospital experience.
Gaughan M, Yap SM, McGuigan C.
O23 11.31 Evaluating the use and impact of Magnetic Resonance Imaging (MRI) in the management of Multiple Sclerosis in Northern Ireland (NI).
Ramsay S, Lammey E, McKee J, Gray O, Hughes S, McDonnell GV, Kennedy F.
O24 11.44 The utility of neurofilaments in clinical predicaments – a preliminary case series examining cerebrospinal fluid neurofilament testing in patients with suspected multiple sclerosis in the west of Ireland.
O’Domhnaill O, Smyth M, Monaghan T
O25 11.57 Accelerated subcortical gray matter and occipital gray matter atrophy occurs following acute optic neuritis: In-vivo evidence for trans-synaptic degeneration in multiple sclerosis.
Murphy OC, Sotirchos ES, Kalaitzidis G, Vasileiou E, Ehrhardt H, Dewey B, Fitzgerald KC, Prince JL, Calabresi PA, Saidha S.
Session X - Noel Callaghan Guest Lecture
12.10 “The spectrum of Tourette Disorder: From semiology, to treatment, and new genetic vistas”. Dr. Jorge Juncos MD, Associate Professor of Neurology, Emory University, USA 13.00 Appreciation and comments Dr. Donal Costigan and
Prof. Kathleen Gorman
Session XI - Neurosurgery and Stroke
O26 14.30 Spontaneous Non-Aneurysmal Subarachnoid Haemorrhage in Northern Ireland – a 5-Year Review.
Browne D, Simms HN.
O27 14.43 Fibromuscular dysplasia: A single centre case series and review of the literature
Durcan R, O'Hare A, O'Donohoe R, McGuigan C.
O28 14.56 Chiari Malformation Presenting with Papilloedema: A Case Report.
Carroll A, Reynolds A, Smyth S
O29 15.25 Characterisation of serum biomarkers of angiographic cerebral vasospasm (ACV) and delayed cerebral ischemia (DCI) in aneurysmal subarachnoid haemorrhage.
Ita M, Toulouse A, Fanning N, Lim C.
O30 15.38 Pathologically proven cerebral amyloid angiopathy related inflammation- A single centre: 10 year experience.
Dudley A, Costelloe L, Moroney J, Looby S, Sweeney K,, Beausang A, Farrell M, McGovern E
O31 15.51 The impact of COVID-19 on trauma in a National Neurosurgical Centre.
Horan J, Duddy, J, Gilmartin B, Amoo M, Nolan D, Corr P, Ben Husien M, Bolger C.
16.05 Two poster presentations selected for Platforms Dr. Ronan Kilbride
Dr. Sinead Murphy
16.20 Presidential Address Dr. Donal Costigan 16.30 Presentation of awards
Harold Millar Prize
John Kirker Prize
Mark Gibson Medal
Hugh Staunton Medal
John Lynch Prize
Dr. Donal Costigan
Posters A - Movement Disorders
A1 Environmental exposure and cutaneous phenotypic clues in Parkinson’s disease- are we detecting them? Chaity DK, Lynch T, Tobin D. A2 Parkinson’s Disease Medication Prescribing and Administration during Unplanned Admissions to a Tertiary Referral Centre: A Retrospective Study. Richard G, Redmond A, Penugonda M, Bradley D. A3 Functional Outcomes Following a Group Exercise and Education Program in Patients with Parkinson’s Disease. Schwartz S, Twomey M, Grover A, Clifford T, O’Sullivan S. A4 The Concurrent Validity of the Dual-Task L-Test in Parkinson's Disease and its Predictive Ability in Identifying Falls. Griffin C, Walsh R, Belton A, Kavanagh N, French HP. A5 Improving inpatient care for patients with Parkinson’ s disease: A multidisciplinary QIP. Penugonda M, Walsh J, Barry JJ, Mc Govern R, Bradley D. A6 Teeth that grind in the night… A case report. Boucher J, Adair S, Doherty K.
Posters B - Multiple Sclerosis
B1 Vaccine hesitancy among people with multiple sclerosis. Yap SM, Al-Hinai MK, Gaughan M, Kearney H, Tubridy N, McGuigan C. B2 Postural stability is an independent predictor of brain atrophy in people with progressive multiple sclerosis. Yap SM, Etzelmueller M, O’Keeffe C, Gaughan M, Simpson D, Kearney H, Tubridy N, Reilly R, Killeen R, McGuigan C.
Posters C - Inflammatory and Immunological
C1 When you hear hoof beats behind you, sometimes it is indeed a zebra! Robinson R, Venkatraman L, McKinley J. C2 Decisions, decisions: Interleukin-6 as a biomarker of disease activity in Neurosarcoidosis. Ali M, Joyce E, Counihan T. C3 A case of angiography – negative Primary Angiitis of the Central Nervous System (PACNS). Boucher JJ, Peukert T, Herron B. C4 Neurological syndromes associated with immune checkpoint inhibitors: A case report and literature review. Ramsay S, Hughes S, Kinney M.
D - Medication audit - Inflammatory
D1 Patient and physician awareness of steroid “sick day rules” – an audit of current practices in the neurology clinic. Bradley M, Hunt I, Elliot S, Troy E, McGovern E. D2 A Review of Rituximab use for neurological indications in MMUH.
Macken E, Kinane S, Melling J, Smyth, S, Munteanu T.
Macken E, Kinane S, Melling J, Smyth, S, Munteanu T. D3 Audit of Blood Test Monitoring in Fingolimod and Dimethyl Fumarate Treated Patients with Active RRMS. Redmond A, Togher Z, Moloney P, Hutchinson S, Bradley D, Redmond J.
Posters E - Stroke and Neurovascular
E1 Performance metrics of the AGGRESTAR PL-12® platelet function analyser in patients with TIA or ischaemic stroke on commonly prescribed antiplatelet regimens. Offiah C, Delaney S, Smith DR, Murphy SJX, Ryan DJ, Collins DR, McCarthy AJ, Egan B, Cox D, McCabe DJH. E2 A rare cause of myelopathy and lower limb spasticity: Giant Cell Arteritis. Dolan E, Byrne R, Barrett J, Osman K, O'Connell P, Shukralla A. E3 Spontaneous subacute spinal cord infarct mimicking longitudinal extensive transverse myelitis. Kalaszi M, Donlon E, Wan Ahmad M, Mohamed A, Boers P. E4 An Audit of Patient Outcomes from the First Level 2 Neuro-Rehabilitation Unit in the Republic of Ireland. O’Brien C, McElligott J, Wallace E, O’Connell K.
Posters F - Neoplasm
F1 Temporary arteritis – a cautionary tale. Smyth M, Monaghan T. F2 Turn the MYC(N) On: A Case of An Aggressive Spinal Ependymoma. Adenan H, Saeed M, Frier D, Dudley A, Elliot S, Burke G, Fitzpatrick D, O’Brien D, Looby S, Brett F, McGovern E. F3 When a bump in the road identifies a mass in the head. Leer M. F4 Development of a Pre-Clinical Model of Melanoma Brain Metastasis using Mouse B16F10-Luc melanoma cells and the characterisation of tissue-blood biomarkers of therapeutic response and disease progression. Ita M, Wang JH, Lim C.H., Redmond HP.
Posters G - Consult Service and Educatioin
G1 Evaluating the impact of an inpatient neurology consultation service in a University Teaching Hospital. Mulkerrin G, Togher Z, Redmond J. G2 NeuroCharades – teaching neurology clinical skills in the Covid-19 era. Smyth M, Costello M, Reid-McDermott B, Walsh S, Browne A, Counihan T. H1 Cytomegalovirus: a viral aetiology of headache. Joyce E, McGrath E, Monaghan T. H2 Neck symptoms as a risk factor for headache: a scoping systematic review. McPartland T, McCool N, Best L, Forbes R H3 Idiopathic Intracranial Hypertension and the Menstrual Cycle: Finding the Link. Redmond A, Togher Z, Penugonda M, Emma Troy E, Hutchinson S.
Posters I - Epilepsy
I1 Review of the association of published cases of status epilepticus and SARS-CoV-19' Cromie D, Kinney M. I2 Ictal Aggression, A Rare Phenomenon: A Case Report and Review of the Literature. Khalil M, Kelly S, Kilbride R, Delanty N, El Naggar H. I3 An early analysis of an ongoing project examining the impact of driving restrictions on patients with epilepsy. Klaus S, Murphy P, Delanty N. I4 Seizures and neurodevelopmental delay caused by a pathogenic variant in gene GRIN2A.' O'Donnell L, Flynn C, Kearney H. I5 Everolimus as a precision therapy for drug-resistant epilepsy caused by mutations in the GATOR1 complex genes DEPDC5 and NPLR3' Moloney P, Doyle M, Kearney H, El-Naggar H, Benson K, Cavalleri GL, Delanty N. I6 Fenfluramine for the Treatment of Dravet Syndrome; A Clinical Case Series Duggan D; Ceballos J, El-Naggar H, Delanty N. I7 Initial Early Access Experience with the Novel Anti-epileptic Drug, Cenobamate, in an Adult Tertiary Referral Centre Colleran N, Ceballos J, Liggan B, Breen A, Widdess Walsh P, El Naggar H, Delanty N. I8 Emergency Neurosurgery for Intractable Epilepsy in Pregnancy: A Case Report. Behan C, Hynes S, Ennis P, Khalil MI, Kilbride R, Brett F, Sweeney K, Doherty C. I9 Readability of online sources of information regarding epilepsy surgery and its impact on decision-making processes. O’Callaghan C, Rogan P, Brigo F, Rahilly J, Kinney M. I10 Late seizures and early cerebral oedema after trivial head injury: Casual or associated with GRIN2A?' O'Carroll J, Stevenson K, Tirupathi S. I11 Survey of status epilepticus care from the perspective of health-care providers In Africa. Marshall C, Olaniyan T, Kinney M. I12 Neurology Waiting lists: Clinical Validation of our chronic problem? Flynn C, Dwyer B, Murphy S, Callanan I, Kearney H.
Posters J -Medication audit - Epilepsy
J1 Valproate use in women of childbearing age in an Irish Neurology clinic. Gan SZ, Gunko A, Cunningham D., Murphy S, O’Dowd S, O’Connell K, McCarthy A. J2 An assessment of the quality of literature regarding anti-seizure medications and human sperm parameters. Campbell I. Kinney M. J3 Qualitative analysis of the portrayal of Sodium Valproate in UK Newspapers over recent decades. Siriwardena S, McAllister N, Islam S, Kinney M
Posters K - Sleep, Coma, Encephalopathy
K1 Ethylene glycol poisoning – clinical and radiological features. Asad M, Gailani G, Henry M, Ryan A. K2 An Audit of bedside EEG in the CUH ICU. Vaughan D, Dineen J, McNamara B. K3 Terrors of the night: An unusual case of sleep-related violence with a multifactorial aetiology. McGettigan J, Donlon E, Gaffney C, Purcell E, Chaila E.
Posters L - Neuromuscular
L1 A Systematic Review and Meta-analysis of Cancer Risk in Myotonic Dystrophy. McConville K, McShane CM, Fallis R, McConville J, Anderson LA. L2 Peripheral nerve vasculitis: a Motor Neurone Disease mimic. Todd R, Donaghy C, Healy E, McConville J, McCarron M, Haffy S. L3 Peripheral neuropathy with concomitant Sars-CoV-2 infection. Joyce E, Gallagher D, Monaghan T. L4 OMG: Is this Miller Fisher Syndrome?! Stevenson K, Moore R, Tirupathi S. L5 Cryptic Limb weakness. Bansal D, Peukert T. L6 A 5-year review of muscle biopsies at St James’s Hospital. Lyons S, Redmond A, Brett F, Redmond J. L7 Paraneoplastic Lymphocytic Myocarditis Associated with Myasthenia Gravis. Bansal D, McConville J. L8 Ockham’s Razor; statins and the liver must be hepatitis! Robinson R, Herron B, McKinley J.
Posters M - Neurophysiology EMG
M1 Reversible conduction failure in anti-GQ1b – associated Guillain-Barré Syndrome. McNicholas N, McGuigan C, Connolly S. M2 Collision technique: a diagnostic adjunct to nerve conduction studies to confirm the presence of Martin-Gruber anastomosis. Heade J, Claffey N, McNicholas N, Connolly S. M3 Congenital thenar hypoplasia masquerading as carpal tunnel syndrome. McKenna MC, Bjerke A, Connolly S. M4 Posterior Interosseous Neuropathy: Distinguishing from a proximal radial neuropathy. McKenna MC, Woods J, O’Riordan S, Dolan R, Connolly S.
Posters N - Ataxia
N1 Frailty, fragility and declining mobility – a case report and literature review of Fragile X-associated tremor/ataxia syndrome. Smyth M, Hennessy M. N2 Establishing a diagnosis of SCA48 in an Irish family. Lyons S, Gunko A, Munteanu T, a Brett F, Walsh R, Redmond J. N3 Amyotrophic spastic ataxia secondary to an ANO10 mutation. Menon P, Elamin M